Insider Transactions in Q2 2023 at Cullinan Oncology, Inc. (CGEM)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Jeffrey Trigilio Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,340
+2.59%
|
$21,060
$9.08 P/Share
|
|
Jun 28
2023
|
Nadim Ahmed President and CEO |
SELL
Open market or private sale
|
Direct |
759
-0.65%
|
$8,349
$11.4 P/Share
|
|
Jun 20
2023
|
Jacquelyn L Sumer Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
291
-0.63%
|
$3,492
$12.94 P/Share
|
|
Jun 20
2023
|
Jeffrey Trigilio Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
399
-0.46%
|
$4,788
$12.94 P/Share
|
|
Jun 20
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
238
-0.26%
|
$2,856
$12.94 P/Share
|
|
Jun 20
2023
|
Jeffrey Alan Jones Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
387
-0.66%
|
$4,644
$12.94 P/Share
|
|
Jun 12
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
176
-0.19%
|
$2,288
$13.11 P/Share
|
|
Jun 12
2023
|
Jeffrey Trigilio Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
319
-0.37%
|
$4,147
$13.11 P/Share
|
|
Jun 07
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
100
-0.11%
|
$1,200
$12.4 P/Share
|
|
Jun 07
2023
|
Jennifer Michaelson Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.11%
|
$400
$4.3 P/Share
|
|
Jun 06
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,900
-11.63%
|
$142,800
$12.31 P/Share
|
|
Jun 06
2023
|
Jennifer Michaelson Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,900
+10.42%
|
$47,600
$4.3 P/Share
|
|
May 23
2023
|
Nadim Ahmed President and CEO |
SELL
Open market or private sale
|
Direct |
707
-0.6%
|
$6,363
$9.15 P/Share
|
|
May 18
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
239
-0.26%
|
$1,912
$8.76 P/Share
|
|
May 18
2023
|
Jacquelyn L Sumer Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
291
-0.63%
|
$2,328
$8.76 P/Share
|
|
May 18
2023
|
Jeffrey Alan Jones Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
394
-0.67%
|
$3,152
$8.76 P/Share
|
|
May 18
2023
|
Jeffrey Trigilio Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
399
-0.46%
|
$3,192
$8.76 P/Share
|
|
May 12
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
193
-0.21%
|
$1,544
$8.78 P/Share
|
|
May 12
2023
|
Jeffrey Trigilio Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
347
-0.4%
|
$2,776
$8.78 P/Share
|
|
Apr 25
2023
|
Nadim Ahmed President and CEO |
SELL
Open market or private sale
|
Direct |
716
-0.61%
|
$7,160
$10.59 P/Share
|
|
Apr 18
2023
|
Jeffrey Alan Jones Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
392
-0.66%
|
$3,920
$10.71 P/Share
|
|
Apr 18
2023
|
Jacquelyn L Sumer Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
290
-0.62%
|
$2,900
$10.71 P/Share
|
|
Apr 18
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
238
-0.26%
|
$2,380
$10.71 P/Share
|
|
Apr 18
2023
|
Jeffrey Trigilio Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
398
-0.45%
|
$3,980
$10.71 P/Share
|
|
Apr 12
2023
|
Jeffrey Trigilio Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
318
-0.36%
|
$3,180
$10.22 P/Share
|
|
Apr 12
2023
|
Jennifer Michaelson Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
176
-0.19%
|
$1,760
$10.22 P/Share
|